Comparing the CK expression between HR+ BC-PDMs and TNBC PDM, we found significantly increased CK18 expression (p = 0.006), a marker for luminal carcinomas, in HR + BC-PDMs (Fig. 3D). Here, KRT18 is linked to breast cancer.